Price
3,846.8
-0.05%52W Range
Market Cap
₹23,967.77 Cr
Traded: ₹193.37 Cr (0.81%) 0.0x
Free Float: ₹8,057.96 Cr (2.40% of FF traded)
Volume · 60D trend
5.02 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +17.0% | +16.0% | -- | +10.0% | Decelerating |
| ROE | -- | +26.0% | +31.0% | -- | -- | Accelerating |
| Return | +17.0% | +4.0% | -18.0% | -34.0% | -- | Decelerating |
| Profit | -- | +16.0% | +43.0% | -- | +41.0% | Stable |
Quarterly Results
Mar 2015
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Dec 2013
Sep 2013
Jun 2013
Mar 2013
Dec 2012
Sep 2012
Jun 2012
Mar 2012
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Mar 2015 | Dec 2014 | Sep 2014 | Jun 2014 | Mar 2014 | Dec 2013 | Sep 2013 | Jun 2013 | Mar 2013 | Dec 2012 | Sep 2012 | Jun 2012 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 231 | 221 | 206 | 191 | 212 | 200 | 190 | 173 | 163 | 157 | 155 | 146 | 146 |
| Expenses | 184 | 171 | 164 | 153 | 165 | 157 | 158 | 160 | 141 | 140 | 135 | 133 | 123 |
| Operating Profit | 47 | 50 | 42 | 38 | 47 | 44 | 32 | 13 | 22 | 16 | 20 | 13 | 22 |
| Other Income | -1 | 0 | 1 | 2 | 0 | -1 | 7 | 7 | -3 | 4 | -10 | -2 | -2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 7 | 8 | 9 | 12 | 9 | 8 | 6 | 6 | 6 | 6 | 5 | 5 |
| Profit Before Tax | 45 | 43 | 35 | 31 | 35 | 33 | 30 | 14 | 13 | 13 | 3 | 5 | 14 |
| Tax % | 34.0% | 36.0% | 33.0% | 33.0% | 38.0% | 34.0% | 34.0% | 36.0% | 36.0% | 31.0% | 37.0% | 29.0% | 25.0% |
| Net Profit | 30 | 28 | 24 | 21 | 22 | 22 | 20 | 9 | 8 | 9 | 2 | 3 | 8 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | -7 | 0 |
| EPS (Rs) | 4.8 | 4.5 | 3.8 | 3.3 | 3.5 | 3.5 | 3.2 | 1.4 | 1.3 | 1.4 | 0.3 | 0.4 | 1.3 |
| Sales Growth (YoY) | 9.3% | 10.7% | 8.4% | 10.2% | 29.4% | 27.7% | 22.3% | 18.4% | 12.3% | 13.6% | 13.1% | 23.9% | 17.8% |
| Sales Growth (QoQ) | 4.5% | 7.3% | 7.8% | -9.9% | 6.0% | 5.3% | 9.8% | 6.1% | 3.8% | 1.3% | 6.2% | 0.0% | -- |
| OP Growth (YoY) | 0.0% | 13.6% | 31.3% | 192.3% | 113.6% | 175.0% | 60.0% | 0.0% | 0.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | -6.0% | 19.0% | 10.5% | -19.1% | 6.8% | 37.5% | 146.2% | -40.9% | 37.5% | -20.0% | 53.8% | -40.9% | -- |
| Profit Growth (YoY) | 36.5% | 28.8% | 18.6% | 132.8% | 168.4% | 146.4% | 178.7% | 4.8% | -1.4% | -14.6% | -34.8% | 67.1% | -26.6% |
| EPS Growth (YoY) | 36.5% | 28.9% | 18.4% | 133.6% | 167.9% | 147.1% | 1003.5% | 240.5% | -1.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | 7.4% | 17.7% | 13.5% | -4.8% | 1.4% | 8.1% | 123.8% | 9.2% | -6.4% | 382.8% | -30.9% | -68.4% | -- |
| OP Margin | 20.4% | 22.6% | 20.4% | 19.9% | 22.2% | 22.0% | 16.8% | 7.5% | 13.5% | 10.2% | 12.9% | 8.9% | 15.1% |
| Net Margin | 13.0% | 12.7% | 11.7% | 11.0% | 10.4% | 11.0% | 10.5% | 5.2% | 4.9% | 5.7% | 1.3% | 2.0% | 5.5% |
| Material Cost % | 10.0% | 9.0% | 8.0% | 8.0% | 11.0% | 7.0% | 7.0% | 0.0% | 9.0% | 9.0% | 11.0% | 10.0% | 0.0% |
| Employee Cost % | 53.0% | 53.0% | 55.0% | 56.0% | 50.0% | 52.0% | 52.0% | 54.0% | 55.0% | 57.0% | 55.0% | 59.0% | 51.0% |
| P/S | 28.23 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 234.85 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 84.69 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Please find enclosed transcript of the Earnings Call held on October 13, 2026.
Please find enclosed copies of Newspaper Publication regarding Audited Financial Results for the quarter and half-year ended September 30, 2026.
Please find enclosed the Audio Recording of the earnings call held today i.e., October 13, 2026 regarding the Q2 FY27 Financial Results.
Please find enclosed the intimation regarding the allotment of 686 equity shares pursuant the exercise of Stock Options by the eligible employees under Tata Elxsi Performance Stock Option Plan 2023.
Please find enclosed Investors Presentation and Fact Sheet on Q2 FY27 Financial Results
Please find enclosed the Press Release for Q2 FY27 Financial Results.
Please find enclosed the intimation regarding appointment of Statutory Auditors of the Company.
Please find enclosed the Audited Financial Results for the quarter and half-year ended September 30, 2026.
Please find enclosed the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Please find enclosed the schedule of Earnings Call in respect of the Audited Financial Results for the quarter and half-year ended September 30, 2026, scheduled on October 13, 2026 at 19:00 Hrs (IST).
Tata Elxsi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve Audited Financial Results for the ....
Please find enclosed the intimation of closure of trading window for the quarter and half-year ending September 30, 2026.
Please find enclosed the intimation for schedule of Analyst/Investor Conference scheduled to be held on September 22, 2026.
Please find enclosed Press Release dated September 10, 2026, titled "Tata Elxsi Invests in KAVIA AI to Scale AI-Driven Software Engineering for Products and Enterprises".
Please find enclosed the newspaper advertisement published today i.e., September 08, 2026 regarding opening of "Special Window for Transfer and Dematerialization of Physical Securities".
Please find enclosed newspaper advertisement published on September 02, 2026, regarding issue of duplicate securities.
Please find enclosed Press Release dated September 01, 2026, titled "Tata Elxsi and Sarla Aviation Partner to Accelerate Development of Shunya, India''s First Indigenous eVTOL Aircraft".
Please find enclosed intimation regarding allotment of 6170 equity shares pursuant to the exercise of Performance Stock Option by the eligible employees under Tata Elxsi Performance Stock ....
Please find enclosed copy of newspaper publication pertaining to issue of duplicate securities published on August 11, 2026
Please find enclosed the Press Release dated July 27, 2026, titled "SCTIMST and Tata Elxsi Forge Strategic Partnership to Accelerate Healthcare Innovation and Medical Technology Development".
Please find enclosed transcript of the earnings call held on July 14, 2026
Please find enclosed copies of the newspaper advertisement published today i.e., July 15, 2026, regarding the Audited Financial Results for the quarter ended June 30, 2026
Please find enclosed Audited Financial Results for the quarter ended June 30, 2026
Please find enclosed Press Release dated July 14, 2026 for Q1 FY27 results
Please find enclosed Investor Presentation on Q1 FY 27 Results
Please find enclosed Audio Recording of the earnings call (Q1 FY27) held on July 14, 2026
Please find enclosed the copies of the newspaper advertisement published today i.e. July 10, 2026, regarding the opening of another "Special Window for Transfer and Dematerialization of ....
Please find enclosed the Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.
Tata Elxsi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/07/2026 ,inter alia, to consider and approve audited financial results for the ....
Please find enclosed the intimation for the Investors Conference Call details in respect of the financial results for the quarter ended June 30, 2026, scheduled on July 14, 2026 at 19:00 (IST)
The Board of Directors have allotted 2,497 equity shares pursuant to the exercise of performance stock options by the eligible employees of the Company
Please refer the enclosed file.
Please find enclosed the Press Release dated June 24, 2026, titled "Tata Elxsi and Sky Mark a Major Milestone in AI-led Autonomous Network Transformation with NEURON"
Please find enclosed proceedings of the 37th Annual General Meeting of Tata Elxsi Limited held today i.e. June 24, 2026.
Please find enclosed the Voting Results and Consolidated Scrutinizer''s Report dated June 24, 2026.
Please find enclosed Intimation of Trading Window Closure for the quarter ending June 30, 2026.
Please find enclosed the intimation letter sent to the Shareholders holding shares in physical form regarding furnishing of their PAN, KYC, Nomination and Bank details as per the SEBI ....
Please find enclosed the newspaper advertisement published intimating the shareholders regarding the 37th Annual General Meeting of the Company scheduled to be held on June 24, 2026.
Please find enclosed intimation of the date of the 37th Annual General Meeting and Record Date for payment of Dividend.
Please find enclosed intimation of the Record Date for the payment of Dividend on equity shares for the financial year 2025-26
Please find enclosed Notice of the 37th Annual General Meeting to be held on June 24, 2026 at 10:30 a.m. (IST) along with Integrated Annual Report for financial year 2025-26.
Please find enclosed the Integrated Annual Report for FY 2025-26 along with the Notice of 37th AGM and other Statutory Reports of Tata Elxsi Limited.
Please find enclosed Business Responsibility and Sustainability Report for FY 2025-26
Please find enclosed letter sent to shareholders of the Company whose email address are not registered with the Company/RTA/Depository Participants.
Please find enclosed disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding Authorization of Key Managerial Personnel of the Company to determine Materiality of Events ....
Please find enclosed the Press Release dated May 27, 2026, titled "Tata Elxsi Launches AnaTelTM, an AI-Native Software Development Platform for Healthcare and Med-Tech Powered by OpenAna".
Please find enclosed the Press Release dated May 26, 2026, titled "Tata Elxsi Launches ViTelTM, a Material Intelligence Solution for Med-Tech Powered by Viridium AI".
Please find enclosed the specimen of the e-mail communication sent to the shareholders whose email addresses are registered, relating to deduction of applicable tax at source from the Dividend ....
Please find enclosed the newspaper advertisement published today viz. May 12, 2026, regarding Notice to the shareholders on proposed transfer of equity shares to IEPF.
Please find enclosed a specimen of the reminder letter sent to those shareholders whose dividend remained unpaid / unclaimed and whose shares are liable to be transferred to IEPF Authority ....
Annual Reports
15Credit Ratings
6Concalls
37Apr 2026
30 Apr 2026Jan 2026
31 Jan 2026Jan 2026
31 Jan 2026Oct 2025
31 Oct 2025Jul 2025
31 Jul 2025Apr 2025
30 Apr 2025Jan 2025
31 Jan 2025Oct 2024
31 Oct 2024Jul 2024
31 Jul 2024Apr 2024
30 Apr 2024Jan 2024
31 Jan 2024Jan 2024
31 Jan 2024Oct 2023
31 Oct 2023Jul 2023
31 Jul 2023May 2023
31 May 2023May 2023
31 May 2023Jan 2023
31 Jan 2023Oct 2022
31 Oct 2022Jul 2022
31 Jul 2022Apr 2022
30 Apr 2022Oct 2021
31 Oct 2021Jul 2021
31 Jul 2021Apr 2021
30 Apr 2021Mar 2021
31 Mar 2021Jan 2021
31 Jan 2021Oct 2020
31 Oct 2020Jul 2020
31 Jul 2020Apr 2020
30 Apr 2020Jan 2020
31 Jan 2020Oct 2019
31 Oct 2019Jul 2019
31 Jul 2019Apr 2019
30 Apr 2019Jan 2019
31 Jan 2019Oct 2018
31 Oct 2018Aug 2018
31 Aug 2018Apr 2018
30 Apr 2018Jan 2018
31 Jan 2018Held by ETFs
35 ETFs hold TATAELXSI · sorted by weight
Held by Mutual Funds
45 schemes hold TATAELXSI · sorted by weight